STOWELL-ORBISON/AUTOPSY and SURGICAL PATHOLOGY AWARDS COMPETITION
Monday, February 28, 2011   9:30 AM - 12:00 Noon
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
LIVER & PANCREAS PATHOLOGY
Title and Authors
Increased FLK-1, PDGFR-α, and BRAF Expression in Hepatocellular Carcinoma: An Immunohistochemical Molecular Mediator Survey.
MA Delgado, X Li, SH Patel, PJ Kneuertz, NV Adsay, C Cohen, SK Maithel, AB Farris - Emory University Hospital, Atlanta, GA
High Level of Hexokinase 2 (HK2) Expression Is Observed in Diabetes, Biologically Aggressive Hepatocellular Carcinomas (HCC), and in the Progression of HCC.
R Chennuri, A Chan, R Patel, TJ Layden, N Hay, SJ Cotler, G Guzman - University of Illinois (UIC), Chicago; UIC, Chicago
Involvement of the Cytosolic Phospholipase A2 alpha Signaling Pathway in Spontaneous and Transforming Growth Factor-beta Induced Hepatic Stellate Cell Activation.
L Zhao, Z-H Gao - University of Calgary and Calgary Laboratory Services, AB, Canada
Reticulin Loss in Benign Fatty Liver: An Important Diagnostic Pitfall When Considering a Diagnosis of Hepatocellular Carcinoma.
AD Singhi, D Jain, S Kakar, T-T Wu, MM Yeh, M Torbenson - Johns Hopkins, Baltimore, MD; Yale, New Haven, CT; UCSF, San Francisco, CA; Mayo, Rochester, MN; U. of Wash., Seattle
Diagnostic Utility of Glutamine Synthetase and Serum Amyloid Associated Protein Immunohistochemistry in the Distinction of Focal Nodular Hyperplasia and Telangiectatic Hepatic Adenoma.
NM Joseph, D Jain, T-T Wu, M Yeh, M Torbenson, S Kakar - UCSF, San Francisco, CA; Yale Univ, New Haven, CT; Mayo, Rochester, MN; Univ of Washington, Seattle; Johns Hopkins, Baltimore, MD
Diagnostic Utility of CD10 in Benign and Malignant Bile Duct Lesions.
M Tretiakova, M Westerhoff, T Antic, J Mueller, E Himmelfarb, H Wang, S-Y Xiao - University of Chicago, IL; Cedars-Sinai Medical Center, Los Angeles
Molecular Analysis of Pancreatic Ductal Carcinoma and Pancreatic Intraepithelial Neoplasia (PanIN): Does PanIN Represent a Precursor to Invasive Ductal Carcinoma or Secondary Cancerization of Ducts.
SJ Bokhari, JF Silverman, SD Finkelstein, A Mohanty - Allegheny General Hospital, Pittsburgh, PA; RedPath Integrated Pathology, Pittsburgh, PA
Identification of eIF3f as a New Tumor Suppressor in Pancreatic Cancer.
J Shi, F Wen, R Zhou, A Bhattacharyya - University of Arizona, Tucson; Fifth People's Hospital of Shanghai, Shanghai, China